Article
[Tumour markers in epithelial ovarian cancer].
Ugeskrift for laeger - 23 Nov 2009
Sparholt Morten H, Høgdall Estrid, Høgdall Claus K
Abstract excerpt
In October 2007, the Danish government and regions made an agreement comprising acute treatment of ovarian cancer (OC) patients. The acute OC-package includes the tumour marker cancer antigen 125 (CA125) as an essential factor. This marker is yet not optimal due to too low sensitivity/specificity. There is therefore a need for new or supplementary markers to improve the treatment. As the agreement will be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
